3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 27 0 0 0 0 0 0 0999 V2000
-2.0941 -3.7826 -0.0057 Br 0 0 0 0 0 0 0 0 0 0 0 0
-2.1387 2.2745 0.0102 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4767 -0.5912 1.1906 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0989 -0.8948 0.0200 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8894 0.2138 -0.0032 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3058 0.9456 -0.0089 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1055 0.9285 0.0063 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6129 0.3107 -0.0203 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8920 -1.1914 -0.0068 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2748 2.3327 -0.0050 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2926 0.2010 0.0119 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0938 -1.8935 -0.0010 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9630 2.9432 0.0046 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2954 -1.1961 0.0083 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2462 0.0019 -1.2113 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2623 -0.0025 1.1569 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4869 -0.5997 -1.1464 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0361 -1.7581 -0.0140 H 0 0 0 0 0 0 0 0 0 0 0 0
1.1785 2.9335 -0.0094 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2472 0.7239 0.0193 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.0495 4.0248 0.0080 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2474 -1.7209 0.0130 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7945 0.2191 -2.1739 H 0 0 0 0 0 0 0 0 0 0 0 0
1.8304 0.2078 2.1297 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0338 -0.8664 -2.0432 H 0 0 0 0 0 0 0 0 0 0 0 0
1 12 1 0 0 0 0
2 7 2 0 0 0 0
2 13 1 0 0 0 0
3 4 2 0 0 0 0
3 16 1 0 0 0 0
4 17 1 0 0 0 0
5 6 2 0 0 0 0
5 7 1 0 0 0 0
5 9 1 0 0 0 0
6 8 1 0 0 0 0
6 10 1 0 0 0 0
7 11 1 0 0 0 0
8 15 1 0 0 0 0
8 16 2 0 0 0 0
9 12 2 0 0 0 0
9 18 1 0 0 0 0
10 13 2 0 0 0 0
10 19 1 0 0 0 0
11 14 2 0 0 0 0
11 20 1 0 0 0 0
12 14 1 0 0 0 0
13 21 1 0 0 0 0
14 22 1 0 0 0 0
15 17 2 0 0 0 0
15 23 1 0 0 0 0
16 24 1 0 0 0 0
17 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
6-bromo-4-pyridazin-4-ylquinoline
4.2 InChl
InChI=1S/C13H8BrN3/c14-10-1-2-13-12(7-10)11(4-5-15-13)9-3-6-16-17-8-9/h1-8H
4.3 InChlKey
AWUZTCWLOWWNTE-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC2=NC=CC(=C2C=C1Br)C3=CN=NC=C3
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病